Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$381.3K
24.38K shares
What this filing means
LORRAIN DANIEL S. plans to sell 24.38K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $381.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009932
Officer· Chief Scientific Officer
Since Mar 2026
24.38K
Shares to sell
$381.3K
Approx. market value
4.17K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/9/2017
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
9.52K
Market value
$154.9K
9/1/2026
—Completed
Units to sell
9.52K
Market value
$151.8K
8/3/2026
—Completed
Units to sell
127.00
Market value
$2.0K
7/31/2026
—Completed
Units to sell
25.00
Market value
$400.00
7/9/2026
—Completed
Units to sell
1.01K
Market value
$16.2K
7/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.17K
Market value
$56.0K
10/1/2026
Total
Units
24.38K
Value
$381.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 9.52K | $154.9K | — | Completed |
8/3/2026 | 9.52K | $151.8K | — | Completed |
7/31/2026 | 127.00 | $2.0K | — | Completed |
7/9/2026 | 25.00 | $400.00 | — | Completed |
7/8/2026 | 1.01K | $16.2K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 4.17K | $56.0K | NASDAQ | Planned |
| Total | 24.38K | $381.3K | ||